The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
25 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $14,903,602 in first-year total cost, median $688,868.
Most frequent study sections
- Special Emphasis Panel[ZMH1 ERB-N (03)]7
- Special Emphasis Panel[ZMH1 ERB-K (04)]6
- Special Emphasis Panel[ZMH1 ERB-B (02)]4
- Special Emphasis Panel[ZMH1 ERB-B (04)]3
- Special Emphasis Panel[ZMH1 ERB-K (07)]3
Most frequent institutions
- UNIVERSITY OF CALIFORNIA LOS ANGELES2
- UNIVERSITY OF WASHINGTON2
- AUGUSTA UNIVERSITY1
- DUKE UNIVERSITY1
- EMORY UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | 1/3 Effectiveness Trial of the Early Social Interaction (ESI) Model using Mobile Technology for Toddlers with Autism Identified from Early Screening in Primary Care1R01MH121627-01A1 | WETHERBY, AMY M | FLORIDA STATE UNIVERSITY, FL | $1,533,662 | ZMH1 |
| 2021 | 1/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial1R01MH120317-01A1 | GIRGIS, RAGY RAMSISSTROUP, THOMAS SCOTT | NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC, NY | $1,432,665 | ZMH1 |
| 2021 | 1/3 Lay-delivered Behavioral Activation in Senior Centers1R01MH124975-01 | RAUE, PATRICK J | UNIVERSITY OF WASHINGTON, WA | $540,929 | ZMH1 |
| 2021 | 2/3 Lay-delivered Behavioral Activation in Senior Centers1R01MH124966-01 | SIREY, JO ANNE | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $360,000 | ZMH1 |
| 2021 | 3/3 Lay-delivered Behavioral Activation in Senior Centers1R01MH124956-01 | GUM, AMBER M | UNIVERSITY OF SOUTH FLORIDA, FL | $320,999 | ZMH1 |
| 2021 | 3/3-Effectiveness Trial of the Early Social Interaction (ESI) Model using Mobile Technology for Toddlers with Autism Identified from Early Screening in Primary Care1R01MH127120-01 | LORD, CATHERINE | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $251,160 | ZMH1 |
| 2021 | 2/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial1R01MH120318-01A1 | GOFF, DONALD C. | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $211,875 | ZMH1 |
| 2021 | 5/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial1R01MH120185-01A1 | LINDENMAYER, JEAN-PIERRE | NATHAN S. KLINE INSTITUTE FOR PSYCH RES, NY | $203,625 | ZMH1 |
| 2021 | 2/3 Effectiveness Trial of the Early Social Interaction (ESI) Model using Mobile Technology for Toddlers with Autism Identified from Early Screening in Primary Care1R01MH121622-01A1 | KLIN, AMISTAPEL-WAX, JENNIFER LAWSON | EMORY UNIVERSITY, GA | $198,558 | ZMH1 |
| 2021 | 3/7 Clozapine for the Prevention of Violence in Schizophrenia: A Randomized Clinical Trial1R01MH120253-01A1 | JARSKOG, LARS FREDRIK | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $194,375 | ZMH1 |
| 2021 | 4/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial1R01MH120354-01A1 | KELLY, DEANNA L | UNIVERSITY OF MARYLAND BALTIMORE, MD | $193,125 | ZMH1 |
| 2021 | 7/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial1R01MH120316-01A1 | MCEVOY, JOSEPH PATRICK | AUGUSTA UNIVERSITY, GA | $192,500 | ZMH1 |
| 2021 | 6//7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial.1R01MH120319-01A1 | KOPELOWICZ, ALEX J | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $157,500 | ZMH1 |
| 2020 | 4/4: Improving the Part C Early Intervention Service Delivery System for Children with ASD: A Randomized Clinical Trial1R01MH122728-01 | CARTER, ALICE S. | UNIVERSITY OF MASSACHUSETTS BOSTON, MA | $982,512 | ZMH1 |
| 2020 | 1/4: Improving the Part C Early Intervention Service Delivery System for Children with ASD: A Randomized Clinical Trial1R01MH122727-01 | STONE, WENDY L. | UNIVERSITY OF WASHINGTON, WA | $715,204 | ZMH1 |
| 2020 | 3/4: Improving the Part C Early Intervention Service Delivery System for Children with ASD: A Randomized Clinical Trial1R01MH122726-01 | WAINER, ALLISON LEIGH | RUSH UNIVERSITY MEDICAL CENTER, IL | $702,363 | ZMH1 |
| 2020 | 2/4: Improving the Part C Early Intervention Service Delivery System for Children with ASD: A Randomized Clinical Trial1R01MH122725-01 | INGERSOLL, BROOKE | MICHIGAN STATE UNIVERSITY, MI | $693,137 | ZMH1 |
| 2019 | 1/2-Building Infrastructure for Community Capacity in Accelerating Integrated Care1R01MH117247-01A1 | ALEGRIA, MARGARITA | MASSACHUSETTS GENERAL HOSPITAL, MA | $946,999 | ZMH1 |
| 2019 | Building Infrastructure for Community Capacity in Accelerating Integrated Care1R01MH117246-01A1 | EDDINGTON, KARI MSTEIN, GABRIELA LIVAS | UNIVERSITY OF NORTH CAROLINA GREENSBORO, NC | $804,862 | ZMH1 |
| 2019 | 2/4 Adapting Treatments for Suicidal College Students: A Multisite Trial1R01MH116062-01A1 | COMPTON, SCOTT N | DUKE UNIVERSITY, NC | $783,962 | ZMH1 |
| 2019 | 2/2 Treating Mothers with ADHD and their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial1R01MH118320-01A1 | CHRONIS-TUSCANO, ANDREA | UNIV OF MARYLAND, COLLEGE PARK, MD | $743,348 | ZMH1 |
| 2019 | 1/2 Treating Mothers with ADHD and their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial1R01MH118313-01A1 | STEIN, MARK A | SEATTLE CHILDREN'S HOSPITAL, WA | $737,836 | ZMH1 |
| 2019 | 3/4 Adapting Treatments for Suicidal College Students: A Multisite Trial1R01MH116050-01A1 | SEELEY, JOHN R | UNIVERSITY OF OREGON, OR | $715,105 | ZMH1 |
| 2019 | 1/4 Adapting Treatments for Suicidal College Students: A Multisite Trial1R01MH116052-01A1 | PISTORELLO, JACQUELINE | UNIVERSITY OF NEVADA RENO, NV | $688,868 | ZMH1 |
| 2019 | 4/4 Adapting Treatments for Suicidal College Students: A Multisite Trial1R01MH116061-01A1 | RIZVI, SHIREEN LEILA | RUTGERS, THE STATE UNIV OF N.J., NJ | $598,433 | ZMH1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.